In a study conducted during the 2013–14 flu season of more than 38,000 residents in 823 nursing homes in 38 states, people 65 and older who got the Fluzone High-Dose vaccine had a lower risk of ...

Whether a high-dose influenza vaccine is associated with a benefit in ... on average, 65, were included. Nearly 75% of subjects were males, 72.3% were White, and 22.3% were Black. About 12.1% ...

The findings, released Tuesday, showed alarming disparities between white adults and adults of color. ... People of color were also less likely to receive a high-dose flu vaccine.

Compared to white adults, people of color in the U.S. are more likely to be hospitalized with the flu and less likely to be vaccinated against the flu, according to a large study the CDC published ...

Sharon resident Valerie White, 74, said the high-dose shot was unavailable at a drug store in her Canton supermarket, but she later found it at a CVS in Sharon.

Black people are about 20% less likely than Wite people to get flu shots, although they are at higher risk of severe flu. Even those who get the vaccine are about 30% less likely to get the high-do… ...

Comparing adjuvanted trivalent flu vaccine with high-dose trivalent flu vaccine, point estimates for 2017-2018 and 2018-2019, there was a non-significant difference between groups (-0.8 and 2.7 ...

Injection of a high-dose influenza vaccine did not affect all-cause death, cardiac or pulmonary hospitalization compared with a lower dose in patients with prior MI or HF hospitalization ...

An infectious disease physician shares exactly why a high-dose flu vaccine is beneficial to those age 65 and older—especially in 2020. Health Health Conditions Published Oct 12, 2020 ...

Black, Hispanic and Native American people continue to be more likely to be hospitalized with the flu—and less likely to be vaccinated against it, according to a federal report.

At an ACIP meeting Wednesday, Sanofi shared years of data showing its Fluzone High-Dose vaccine, which is indicated for people over the age of 65, is more efficacious than a standard flu shot dose.

Pediatric recipients of hematopoietic-cell transplants (HCT) are at high risk for influenza-related illness and death. They also have weaker humoral immune responses to influenza vaccination than ...